Skip to main content
. Author manuscript; available in PMC: 2009 Jun 1.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2008 Apr 24;28(6):1111–1116. doi: 10.1161/ATVBAHA.108.162347

Figure 6. Effects of platelet agonists PAR4 peptide and ADP on platelet aggregation.

Figure 6

Platelet-rich plasma from WT (black lines) and SR-BI KO (gray lines) were isolated and platelet aggregation as a function of time after adding the agonists PAR4 peptide (1 mM, panel A) or ADP (1 μM, panel B) was measured as increased light transmission in an aggregometer as described in Methods. Aggregation traces from one of three independent experiments are shown.